Lack of Differential Sensitivity to Cholinesterase Inhibition in Fetuses and Neonates Compared to Dams Treated Perinatally with Chlorpyrifos
Authors:
- Jacques P. J. MaurissenJMJacques P. J. Maurissen
- Kathy A. BrzakKBKathy A. Brzak
Open Access
- 1 February 2000
- journal article
- research article
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 53 (2) , 438-446
Abstract
Pregnant Sprague-Dawley rats were exposed to chlorpyrifos (CPF; O,O-diethyl-O-[3,5,6-trichloro-2-pyridinyl] phosphorothioate) by gavage (in corn oil) from gestation day (GD) 6 to postnatal day (PND) 10. Dosages to the dams were 0 (control), 0.3 (low), 1.0 (middle) or 5.0 mg/kg/day (high). On GD 20 (4 h post gavage), the blood CPF concentration in fetuses was about one half the level found in their dams (high-dose fetuses 46 ng/g; high-dose dams 109 ng/g). CPF-oxon was detected only once; high-dose fetuses had a blood level of about 1 ng/g. Although no blood CPF could be detected (limit of quantitation 0.7 ng/g) in dams given 0.3 mg/kg/day, these dams had significant inhibition of plasma and red blood cell (RBC) ChE. In contrast, fetuses of dams given 1 mg/kg/day had a blood CPF level of about 1.1 ng/g, but had no inhibition of ChE of any tissue. Thus, based on blood CPF levels, fetuses had less cholinesterase (ChE) inhibition than dams. Inhibition of ChE occurred at all dosage levels in dams, but only at the high-dose level in pups. At the high dosage, ChE inhibition was greater in dams than in pups, and the relative degree of inhibition was RBC ≈ plasma ≥ heart > brain (least inhibited). Milk CPF concentrations were up to 200 times those in blood, and pup exposure via milk from dams given 5 mg/kg/day was estimated to be 0.12 mg/kg/day. Therefore, the dosage to nursing pups was much reduced compared to the dams exposure. In spite of exposure via milk, the ChE levels of all tissues of high-dosage pups rapidly returned to near control levels by PND 5.Keywords
This publication has 19 references indexed in Scilit:
- Gestational Exposure to Chlorpyrifos: Apparent Protection of the Fetus?Toxicology and Applied Pharmacology, 1998
- Age-Related Differences in Parathion and Chlorpyrifos Toxicity in Male Rats: Target and Nontarget Esterase Sensitivity and Cytochrome P450-Mediated MetabolismToxicology and Applied Pharmacology, 1997
- Neurochemical and neurobehavioral effects of repeated gestational exposure to chlorpyrifos in maternal and developing ratsPharmacology Biochemistry and Behavior, 1996
- Maturational differences in chlorpyrifos-oxonase activity may contribute to age-related sensitivity to chlorpyrifosJournal of Biochemical Toxicology, 1996
- Developmental Neurotoxicity of Chlorpyrifos: Cellular MechanismsToxicology and Applied Pharmacology, 1995
- Computer Simulation of the Lactational Transfer of Tetrachloroethylene in Rats Using a Physiologically Based ModelToxicology and Applied Pharmacology, 1994
- Comparison of in vivo cholinesterase inhibition in neonatal and adult rats by three organophosphorothioate insecticidesToxicology, 1991
- Physiologically based pharmacokinetic modeling of the lactating rat and nursing pup: A multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acidToxicology and Applied Pharmacology, 1990
- Role of lipoprotein lipase activity on lipoprotein metabolism and the fate of circulating triglycerides in pregnancyAmerican Journal of Obstetrics and Gynecology, 1988
- The role of hepatic biotransformation in mediating the acute toxicity of the phosphorothionate insecticide chlorpyrifosToxicology and Applied Pharmacology, 1984